What is the optimal anticoagulation in patients with a left ventricular assist device? - Wikidata - awgldk - TriplyDB

What is the optimal anticoagulation in patients with a left ventricular assist device?

What is the optimal anticoagulation in patients with a left ventricular assist device?

http://www.wikidata.org/entity/Q36242928

about

Complications of Continuous-Flow Mechanical Circulatory Support Devices.Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations.Thrombolytics in VAD management - A single-center experience Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device Mechanical circulatory support for heart failure: past, present and a look at the future.Past and present of cardiocirculatory assist devices: a comprehensive critical review.Management of patients with implanted ventricular assist devices for noncardiac surgery: a clinical review.Diagnosis, nonsurgical management, and prevention of LVAD thrombosis.Use of Heparin in Acute Ischemic Stroke: Is There Still a Role?Cardiovascular causes of emergency neurology presenting to an ICU.Treatment of the acquired von Willebrand syndrome.[Intensive care treatment of patients with left ventricular assist devices].Covering implantable left ventricular assist device (DuraHeart) with free flap.Intravenous thrombolytic therapy for patients with ventricular assist device thrombosis: An attempt to avoid reoperation.Radical Cystectomy with Ileal Conduit Urinary Diversion in a Patient with a Left Ventricular Assist Device.Resolution of hemolysis from pump thrombus during left ventricular assist device exchange.Ventricular assist devices: initial orientation.Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, Brazil.Optical Dynamic Analysis of Thrombus Inside a Centrifugal Blood Pump During Extracorporeal Mechanical Circulatory Support in a Porcine Model.Reliability of the Thoratec HeartMate II flow measurements and alarms in the presence of reduced or non-existent flow.Improving anticoagulation of patients with an implantable left ventricular assist device Management of epistaxis in patients with ventricular assist device: a retrospective review

P2860

Q30409848-FFF1F97D-7966-453F-BDEE-4B47AC84100E Q33440296-0F64078A-040A-4BE8-A5DC-07AC1E5941D7 Q33773690-01A8B8CF-B413-4214-ACD7-02D7F73FB32D Q34159316-9F51E291-894C-43A7-8BFD-23FE68924EDB Q38070702-59C12E2C-7EC3-4356-8ACE-CCBFB26FB79F Q38076112-EAF88EF1-41C6-4F3F-9477-F43C4E4DB760 Q38153202-94901DE0-FE79-479C-B68E-CEA55158A5F8 Q38165430-47A2B08E-E330-4DDE-9B8A-A4CB34C5294F Q38550913-3ADD6F70-8460-4BF1-9AB6-127D3A0ADB0E Q38614547-29F176CE-C4F7-4BAC-8F03-F2B1DFFDF4E5 Q38636087-612B22C4-6315-4657-B1CD-53A7A5D6513E Q41029402-47C11418-3FD8-49F4-B905-11D345AAC689 Q41585069-BBF47390-0B19-43B2-B5BF-B89DCF3B9DAD Q41947306-3CB426BD-440E-42AF-BD0B-3775951FE5CD Q41988453-2822B4D4-06C3-4957-A087-40BE68026B4C Q41992100-7F60A982-E616-4795-9264-8D728F2B3E2C Q42574934-7ADE7721-A5A7-457B-ABC1-0B36E8E26CA5 Q44172490-F7966EA4-E65B-47D4-A737-B8F481C9288E Q50786783-30CE4E84-0C60-4AE3-8EE1-2BD381BEE329 Q51830231-A271FB35-E595-490C-8FE2-86BB91275E30 Q57298250-22F5CB02-A4AA-4486-BF5B-123E548C06E5 Q58803186-3CD287F9-FB39-48D2-9C6D-DA220F3122E5

P2860

What is the optimal anticoagulation in patients with a left ventricular assist device?

http://www.wikidata.org/entity/Q36242928

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

What is the optimal anticoagulation in patients with a left ventricular assist device?

@ast

What is the optimal anticoagulation in patients with a left ventricular assist device?

@en

type

label

What is the optimal anticoagulation in patients with a left ventricular assist device?

@ast

What is the optimal anticoagulation in patients with a left ventricular assist device?

@en

prefLabel

What is the optimal anticoagulation in patients with a left ventricular assist device?

@ast

What is the optimal anticoagulation in patients with a left ventricular assist device?

@en

P1433

Q36242928-468F0A89-732E-4F55-8C01-F9AE8EDF40DA

P1476

Q36242928-FA6B9D6E-E5AF-4166-B22D-38E377F95D65

P2093

Q36242928-07D6C47D-5828-4457-8E59-CC0239841829

Q36242928-4A06569A-43E5-4064-923F-C1C3EEA4E6BD

Q36242928-82B40827-5D24-4D1F-8A18-C96B39A19331

Q36242928-876C7EF2-9262-427C-A0DF-391387BEC736

P2860

Q36242928-045D6C0C-FC61-4CBD-ADE3-4494BFF7F255

Q36242928-169EF70A-C03A-4371-8665-567CA94EB052

Q36242928-225EB66C-BA66-4E94-A94E-599459DAD12E

Q36242928-42167B37-8BD2-4EC1-B969-C0D22E853EAE

Q36242928-4839FD8E-9149-4EAC-A571-6A8F64CA8342

Q36242928-50D15517-6402-4211-84CB-729EA23BBED8

Q36242928-54D9095D-E8CE-4E0F-867A-E99523306A0A

Q36242928-76FACDB4-815F-4776-9E18-A79A383BC65B

Q36242928-7F743F67-ADB4-4385-AF21-EFD710700CDA

Q36242928-C4EC80D9-D956-4F64-BD66-6B77146310D5

P304

Q36242928-B1641B60-4EF5-4A23-9812-405F7DD7377A

P31

Q36242928-142B9F94-8DEB-40EE-BA36-F285673DA120

P356

Q36242928-19B02750-29EE-46FD-A27B-1393E4BB852B

P433

Q36242928-B1937D69-F1B3-4A89-BA7C-0AC2D1EE3014

P478

Q36242928-9FC75007-BEFE-4615-9F6A-D3BA617857D9

P577

Q36242928-5D88B7D0-B2FC-44E9-8733-80E3D50D6AC9

P5875

Q36242928-BABE70ED-3FCB-4DB2-A345-38A84F2F9430

P698

Q36242928-41726454-6861-40EA-BC0D-01F12EFEA9B2

P921

Q36242928-0266B4FA-B5FA-4F45-B430-9A86CF766AD8

P932

Q36242928-729F1D54-C2B0-4209-85E2-E4AFE9D1B706

P356

P1433

Interactive cardio and thoracic surgery

P1476

What is the optimal anticoagulation in patients with a left ventricular assist device?

@en

P2093

Attilio Renzulli

http://www.w3.org/2001/XMLSchema#string

Federica Jiritano

http://www.w3.org/2001/XMLSchema#string

Giuseppe Filiberto Serraino

http://www.w3.org/2001/XMLSchema#string

Michele Rossi

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants

Cerebrovascular accidents in patients with a ventricular assist device.

Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation.

Discontinuation of antithrombotic therapy for a year or more in patients with continuous-flow left ventricular assist devices.

Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD.

A method for anticoagulation of children on mechanical circulatory support.

Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.

Safety and effectiveness of low dosing of double antiplatelet therapy during long-term left ventricular support with the INCOR system.

Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device.

Reliable long-term non-pulsatile circulatory support without anticoagulation.

P304

733-740

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ICVTS/IVS297

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228115881

http://www.w3.org/2001/XMLSchema#string

P698

22761118

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

P932

3445379

http://www.w3.org/2001/XMLSchema#string